*ST Sanfang announced that as of the disclosure date of the announcement, the balance of accounts receivable related to the company was 3.491 billion yuan, a decrease of 694.08 million yuan from the date of disclosure of the annual report, and is continuing to be recovered. Helen Petrochemical, a subsidiary of the company, signed an agreement with related parties Jiangyin Gaorun Investment and Jiangyin Qingyu Investment to transfer 100% of the shares of Jiangyin Sanli Sewage Treatment Co., Ltd. held by the two, at a transaction price of RMB 1,80224 million; Helen Petrochemical's claim of RMB 1,80224 million against Jiangyin Huasheng Polymerization Co., Ltd. offset the equity transfer amount in equal amounts. After the transaction is completed, the balance of related accounts receivable will be $3.473 billion, a decrease of $87.432 million from the date of disclosure of the annual report. This transaction constitutes a related transaction. It has been reviewed and approved by the board of directors of the company. There is no need to submit it to the shareholders' meeting for review. There is still uncertainty about whether the debt can be settled.

*ST Sanfang announced that as of the disclosure date of the announcement, the balance of accounts receivable related to the company was 3.491 billion yuan, a decrease of 694.08 million yuan from the date of disclosure of the annual report, and is continuing to be recovered. Helen Petrochemical, a subsidiary of the company, signed an agreement with related parties Jiangyin Gaorun Investment and Jiangyin Qingyu Investment to transfer 100% of the shares of Jiangyin Sanli Sewage Treatment Co., Ltd. held by the two, at a transaction price of RMB 1,80224 million; Helen Petrochemical's claim of RMB 1,80224 million against Jiangyin Huasheng Polymerization Co., Ltd. offset the equity transfer amount in equal amounts. After the transaction is completed, the balance of related accounts receivable will be $3.473 billion, a decrease of $87.432 million from the date of disclosure of the annual report. This transaction constitutes a related transaction. It has been reviewed and approved by the board of directors of the company. There is no need to submit it to the shareholders' meeting for review. There is still uncertainty about whether the debt can be settled.